Neuroscientific Biopharmaceuticals Ltd (NSB) — Cash Flow Quality Index
Neuroscientific Biopharmaceuticals Ltd (NSB) has a Cash Flow Quality Index of 1.04x as of June 2024. Operating cash flow of AU$1.62 Million exceeds net income of AU$1.55 Million, indicating high earnings quality where cash backs reported profits. Explore NSB cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Neuroscientific Biopharmaceuticals Ltd Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Neuroscientific Biopharmaceuticals Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NSB cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Neuroscientific Biopharmaceuticals Ltd (2024–2024)
Year-by-year earnings quality comparison for Neuroscientific Biopharmaceuticals Ltd. For live market cap and the full company financial profile, see Neuroscientific Biopharmaceuticals Ltd stock valuation.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | AU$44.25K | AU$324.21K | — |